Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

FUNDING. Supported by NCATS (5UL1TR001442), NIDDK (U01DK061734, U01DK130190, R01DK106419, R01DK121378, R01DK124318, P30DK120515, K23DK119460), NHLBI (P01HL147835), and NIAAA (U01AA029019); Academy of Finland grant 309263; the Novo Nordisk, EVO, and Sigrid Juselius Foundations; and the Innovative Med...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of Clinical Investigation 2022, Vol.132 (21)
Hauptverfasser:	Tamaki, Nobuharu, Ahlholm, Noora, Luukkonen, Panu K, Porthan, Kimmo, Sharpton, Suzanne R, Ajmera, Veeral, Kono, Yuko, Dave, Shravan, Ahmed, Aijaz, Sundaram, Vinay, Wilkinson, Michael J, Patton, Heather, Gupta, Hersh, Cervantes, Vanessa, Hernandez, Christie, Lopez, Scarlett J, Loomba, Ria, Baumgartner, Amanda, Richards, Lisa, Arkkila, Perttu E.T, Nemes, Katriina, Isoniemi, Helena, Yki-Jarvinen, Hannele, Loomba, Rohit
Format:	Report
Sprache:	eng
Schlagworte:	Complications and side effects Familial diseases Fatty liver Genetic aspects Liver cirrhosis Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FUNDING. Supported by NCATS (5UL1TR001442), NIDDK (U01DK061734, U01DK130190, R01DK106419, R01DK121378, R01DK124318, P30DK120515, K23DK119460), NHLBI (P01HL147835), and NIAAA (U01AA029019); Academy of Finland grant 309263; the Novo Nordisk, EVO, and Sigrid Juselius Foundations; and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement 777377. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and the EFPIA.
ISSN:	0021-9738
DOI:	10.1172/JCI162513